click below
click below
Normal Size Small Size show me how
Endocrine 1,2,3
Generic | Brand | Pharmacologic Category | Indication | Side Effects |
---|---|---|---|---|
Metformin (PO) | Glucophage, Glucophage XR | Biguanide | Type 2 DM, PCOS | diarrhea, nausea, vomiting US Boxed Warning: lactic acidosis |
Sitagliptin (PO) | Januvia | Dipeptidyl peptidase (DPP-4) inhibitor | Type 2 DM | headache, nasopharyngitis |
Empagliflozin (PO) | Jardiance | Na-glucose cotransporter inhibitor 2 (SGLT2 inhibitor) | Type 2 DM, HF | UTI |
Glimepiride (PO) | Amary | Sulfonylurea | Type 2 DM | hypoglycemia, weight gain |
Glipizide (PO) | Glucotrol, Glucotrol XL | Sulfonylurea | Type 2 DM | hypoglycemia, weight gain |
Glyburide (PO) | Glynase | Sulfonylurea | Type 2 DM | hypoglycemia, weight gain |
Pioglitazone (PO) | Actos | Thiazolidinedione (TZD) | Type 2 DM | edema, weight gain, upper respiratory tract infection Boxed Warning: may exacerbate congestive HF & CI in NYHA Class III and IV |
Liraglutide (SQ) | Victoza, Saxenda | Glucagon-like peptide-1 (GLP-1) receptor agonist | Type 2 DM, chronic weight management | nausea, vomiting, diarrhea, constipation Boxed Warning: may increase risk of thyroid c-cell tumoR |
Insulin detemir (SQ) | Levemir | Insulin, long acting | Type 1 DM, type 2 DM | hypoglycemia, weight gain |
Insulin glargine (SQ) | Lantus, Toujeo, Basaglar | Insulin, long acting | Type 1 DM, type 2 DM | hypoglycemia, weight gain |
Insulin NPH (SQ) | Humulin N, Novolin N | Insulin, intermediate acting | Type 1 DM, type 2 DM | hypoglycemia, weight gain |
Insulin aspart (SQ) | Novolog | Insulin, rapid acting | Type 1 DM, type 2 DM | hypoglycemia, weight gain |
Insulin lispro (SQ) | Humalog | Insulin, rapid acting | Type 1 DM, type 2 DM | hypoglycemia, weight gain |
Insulin regular (SQ, IV) | Humulin R, Novolin R | Insulin, short-acting | Type 1 DM, type 2 DM, DKA | hypoglycemia, weight gain |
Levothyroxine (PO, IV) | Synthroid, Levoxyl | Thyroid product | Hypothyroidism | weight loss, palpitations, diarrhea, insomnia, heat intolerance Boxed Warning: not intended for weight loss Notes: narrow therapeutic index drug (monitoring recommended); not all generic products are therapeutically equivalent |
Thyroid, dessicated (PO) | Armour Thyroid | Thyroid product | Hypothyroidism | weight loss, palpitations, diarrhea, insomnia, heat intolerance Boxed Warning: not intended for weight loss Notes: narrow therapeutic index drug (monitoring recommended); not all generic products are therapeutically equivalent |
Sitagliptin & Metformin (PO) | Janumet, Janumet XR | |||
Drospirenone & ethinyl estradiol (PO) | Yasmin, Yaz | Contraceptive | Contraception, acne | nausea, change in menstrual flow, breast tenderness, thromboembolic disorders, HA| Boxed Warning: increased risk of CV events in women >35 yo who smoke Notes: CI in hepatic dysfunction, thromboembolic disorders, breast cancer & CV disease |
Levonorgestrel & ethinyl estradiol (PO) | Lutera, Levora, Seasonique | Contraceptive | Contraception, acne | nausea, change in menstrual flow, breast tenderness, thromboembolic disorders, HA| Boxed Warning: increased risk of CV events in women >35 yo who smoke Notes: CI in hepatic dysfunction, thromboembolic disorders, breast cancer & CV disease |
Norethindrone & ethinyl estradiol (PO) | Junel, Loestrin, Microgestin | Contraceptive | Contraception, acne | nausea, change in menstrual flow, breast tenderness, thromboembolic disorders, HA| Boxed Warning: increased risk of CV events in women >35 yo who smoke Notes: CI in hepatic dysfunction, thromboembolic disorders, breast cancer & CV disease |
Norethindrone, ethinyl estradiol & ferrous fumarate (PO) | Lo Loestrin Fe, Microgestin Fe | Contraceptive | Contraception, acne | nausea, change in menstrual flow, breast tenderness, thromboembolic disorders, HA| Boxed Warning: increased risk of CV events in women >35 yo who smoke Notes: CI in hepatic dysfunction, thromboembolic disorders, breast cancer & CV disease |
Norgestimate & ethinyl estradiol (PO) | Ortho Tri-Cyclen Lo, Tri-Sprintec, Sprintec | Contraceptive | Contraception, acne | nausea, change in menstrual flow, breast tenderness, thromboembolic disorders, HA| Boxed Warning: increased risk of CV events in women >35 yo who smoke Notes: CI in hepatic dysfunction, thromboembolic disorders, breast cancer & CV disease |
Norgestrel & ethinyl estradiol (PO) | Crysell-28, Low-Ogestrel | Contraceptive | Contraception, acne | nausea, change in menstrual flow, breast tenderness, thromboembolic disorders, HA| Boxed Warning: increased risk of CV events in women >35 yo who smoke Notes: CI in hepatic dysfunction, thromboembolic disorders, breast cancer & CV disease |
Estrogens, conjugated (equine) (PO, topical) | Premarin | Estrogen derivative | Vasomotor symptoms & vaginal atrophy associated w/ menopause | application site irritation (patch) abdominal pain, breast tenderness, CI - thromboembolic disorders (MI, stroke, VTE) Box Warning: increased risk of breast & endometrial cancer (if not used w/ progestin in women w/ uterus) should not be used for CV di |
Estradiol (transdermal, PO) | Transdermal: Vivelle Dot, PO: Estrace | Estrogen derivative | Vasomotor symptoms & vaginal atrophy associated w/ menopause | |
Medroxyprogesterone (PO) | Provera | Progestin | Abnormal uterine bleeding, secondary amenorrhea | acne, HA, amenorrhea abnormal menstrual bleeding, Box Warning: increased risk of breast cancer; DNU for dementia or CV disease prevention | CI in thromboembolic disorders, CV disease, estrogen/ progesterone dependent tumors, undiagnosed abnormal genital b |
Testosterone gel (topical) | AndroGel, Fortesta, Vogelxo | Androgen | Hypogonadism | contact dermatitis, acne, increased PSA, emotional lability, HTN BW:secondary exposure may result in virilization (especially in children); CI in males w/ breast or prostate cancer & pregnant women |
Alendronate (PO) | Fosamax | Bisphosphonate | Osteoporosis | dyspepsia, GERD hypocalcemia, atypical fractures, osteonecrosis of jaw CI in pts w/ esophagus abnormalities admin ≥30 min before food/drink (except plain water); remain upright 30 min following dose to reduce esophageal irritation |
Ibandronate (PO, IV) | Boniva | Bisphosphonate | Osteoporosis | dyspepsia, GERD hypocalcemia, atypical fractures, osteonecrosis of the jaw PO: CI in pts w/ esophagus abnormalities; admin ≥60 min before food/drink (except plain water); remain upright for 60 min after dose to reduce esophageal irritation |
Raloxifene (PO) | Evista | Selective estrogen receptor modulator (SERM) | Osteoporosis, breast cancer prevention | hot flashes, leg cramps, peripheral edema, arthralgia BW: increased risk of thromboembolism,death caused by stroke in pts with CV disease |
Sildenafil (PO) | Viagra, Revatio | Phosphodiesterase-5 enzyme (PDE5) inhibitor | ED, PAH (pulmonary arterial HTN) | priapism, HA, flushing, visual disturbance CI w/ concomitant use of nitrates (may cause severe hypotension) |
Tadalafil (PO) | Cialis | Phosphodiesterase-5 enzyme (PDE5) inhibitor | ED, BPH | priapism, HA, flushing, visual disturbance CI w/ concomitant use of nitrates (may cause severe hypotension) |